Seer Reports 34% Revenue Drop, Increased Cash Burn Amidst Activist Battle; Continues Share Repurchases and Poison Pill Defense

summarizeSummary

Seer, Inc. reported a 34% year-over-year revenue decline and increased operating cash burn in Q1 2026, while continuing its share repurchase program and maintaining a poison pill defense against an activist investor.

check_boxKey Events

• Significant Revenue Decline

  Total revenue decreased by 34% year-over-year to $2.79 million in Q1 2026, driven by lower product and service sales.

• Increased Operating Cash Burn

  Cash used in operating activities increased by 35% to $15.4 million in Q1 2026, indicating a faster rate of cash depletion.

• Substantial Share Repurchase Activity

  The company repurchased 1.46 million shares for $2.62 million in Q1 2026 at an average price of $1.78 per share, with $25.5 million remaining under the program. This represents a significant commitment relative to the company's market capitalization and current stock price.

• Liquidity Runway Maintained

  Management projects sufficient capital resources to continue operations for at least 12 months, with $219.5 million in cash and investments as of March 31, 2026.

auto_awesomeAnalysis

This quarterly report highlights a significant decline in Seer's core business, with revenue down 34% and gross profit down 52% year-over-year. The increased cash burn from operations (up 35%) is a major concern, especially as the company trades near its 52-week low. These financial results are critical in the context of the ongoing activist investor campaign, which has seen the Board reject multiple acquisition proposals. The company's substantial share repurchase activity and the adoption of a poison pill are clear defensive maneuvers, but the deteriorating business performance could intensify pressure from the activist group.